User profiles for Marc Bertrand

Marc Bertrand

Université de Montréal
Verified email at umontreal.ca
Cited by 22

Characterizing novice behavior associated with learning ultrasound-guided peripheral regional anesthesia

…, JD Gallagher, CW Wiley, ML Bertrand… - Regional Anesthesia & …, 2007 - rapm.bmj.com
Background and Objectives: Ultrasound-guided regional anesthesia is a rapidly growing
field. There exists little information regarding the competencies involved with such a practice. …

S32826, a nanomolar inhibitor of autotaxin: discovery, synthesis and applications as a pharmacological tool

…, M Beucher-Gaudin, M Lonchampt, M Bertrand… - … of Pharmacology and …, 2008 - ASPET
Autotaxin catalyzes the transformation of lyso-phosphatidylcholine in lyso-phosphatidic acid
(LPA). LPA is a phospholipid possessing a large panel of activity, in particular as a motility …

Functional expression of sinusoidal drug transporters in primary human and rat hepatocytes

…, M Le Vee, C Boursier-Neyret, M Bertrand… - Drug metabolism and …, 2005 - ASPET
Primary hepatocyte cultures are considered as a useful in vitro system for pharmacological/toxicological
studies. Although expression of drug-metabolizing enzymes and canalicular …

NMR Study of Lithium Transport in Liquid–Ceramic Hybrid Solid Composite Electrolytes

G Foran, A Mery, M Bertrand, S Rousselot… - … Applied Materials & …, 2022 - ACS Publications
Despite their high conductivity, factors such as being fragile enough to face processing
issues and interfacial incompatibility with lithium electrodes are some of the main drawbacks …

S29434, a quinone reductase 2 inhibitor: main biochemical and cellular characterization

…, F Nepveu, K Reybier, P Dupuis, M Bertrand… - Molecular …, 2019 - ASPET
Quinone reductase 2 (QR2, EC 1.10.5.1) is an enzyme with a feature that has attracted
attention for several decades: in standard conditions, instead of recognizing NAD(P)H as an …

Rapid assessment of drug metabolism in the drug discovery process

M Bertrand, P Jackson, B Walther - European journal of pharmaceutical …, 2000 - Elsevier
For a few years, in vitro models have been used as part of high-throughput screening (HTS)
programs to characterize metabolic stability, drug permeability and drug solubility. This has …

Prediction of interindividual variation in drug plasma levels in vivo from individual enzyme kinetic data and physiologically based pharmacokinetic modeling

…, R Jochemsen, P Jackson, M Bertrand… - European journal of …, 2000 - Elsevier
A strategy is presented to predict interindividual variation in drug plasma levels in vivo by
the use of physiologically based pharmacokinetic modeling and human in vitro metabolic …

Solid-phase synthesis of α-substituted 3-bisarylthio N-hydroxy propionamides as specific MMP inhibitors

…, N Kucharczyk, A Loynel, M Bertrand… - Bioorganic & medicinal …, 2002 - Elsevier
… Author links open overlay panel Anne-Marie Chollet a , Thierry Le Diguarher a , Nathalie
Kucharczyk a , Armelle Loynel a , Marc Bertrand c , Gordon Tucker b , Nicolas Guilbaud b …

Stereospecific synthesis of 5-substituted 2-bisarylthiocyclopentane carboxylic acids as specific matrix metalloproteinase inhibitors

T Le Diguarher, AM Chollet, M Bertrand… - Journal of medicinal …, 2003 - ACS Publications
The synthesis and structure−activity relationship (SAR) studies of a series of cyclopentane
carboxylic acid matrix metalloproteinase (MMP) inhibitors are described. Potent and specific …

Substituted benzocyloheptenes as potent and selective αv integrin antagonists

F Perron-Sierra, D Saint Dizier, M Bertrand… - Bioorganic & medicinal …, 2002 - Elsevier
A novel series of potent and specific α v integrin antagonists has been obtained by aminoalkyl
substitutions on benzocyloheptene acetic acids as a rigid GD bioisostere. The preferred …